Tue, Sep 16, 2014, 7:03 PM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Genomic Health Inc. Message Board

  • rothingham rothingham Jul 12, 2012 7:32 AM Flag

    GHDX profits vs competition

    New to ghdx, still doing my early due diligence on both the stock and the market. Am I correct that MYGN is a competitor, and if so, why is MYGN's profits (cash flow, operating cash flow, EBITDA) so much higher than GHDX? CPHD, which I also believe is a competitor, is right in line with GHDX. Comments and assistance from those much more knowledgeable than me greatly appreciated.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • With $1b of revenue, ghdx has $15m ebitda, $23m operating cash flow and $14m free cash flow. With twice the revenue ($2b), mygn has $184m ebitda, $136m operating cash flow, and $122m free cash flow. All figures via Yahoo. mygn is obviously an extremely profitable company, but I dont know if it is a true apples to apples comparison with ghdx and cphd. Any help appreciates.

28.94+0.66(+2.33%)Sep 16 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.